Sartorius’ Biopharmaceutical Manufacturing Facility Expansion, Puerto Rico

SourcePharmaceutical Technology
Date Published06/30/2019
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Sartorius Stedim
Parent companySartorius Group
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2016
Year reshoring implemented or to be implemented:2019
Capital investment ($):100
City reshored to:Yauco
State(s) reshored to:PR
If relevant, work nearshored to:-
Product(s) reshoredbiopharm bags
What domestic positive factors made reshoring more attractive?Eco-system synergies, Infrastructure, Proximity to customers/market
Find Reshoring Articles